These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 26923470)
1. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors. Clooney AG; Bernstein CN; Leslie WD; Vagianos K; Sargent M; Laserna-Mendieta EJ; Claesson MJ; Targownik LE Aliment Pharmacol Ther; 2016 May; 43(9):974-84. PubMed ID: 26923470 [TBL] [Abstract][Full Text] [Related]
2. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study. Castellani C; Singer G; Kashofer K; Huber-Zeyringer A; Flucher C; Kaiser M; Till H Front Cell Infect Microbiol; 2017; 7():444. PubMed ID: 29075620 [TBL] [Abstract][Full Text] [Related]
4. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes. Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012 [TBL] [Abstract][Full Text] [Related]
5. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies. Macke L; Schulz C; Koletzko L; Malfertheiner P Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420 [TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota Characteristics in Children After the Use of Proton Pump Inhibitors. Simakachorn L; Tanpowpong P; Chanprasertyothin S; Thongpradit S; Treepongkaruna S Turk J Gastroenterol; 2021 Jan; 32(1):70-75. PubMed ID: 33893768 [TBL] [Abstract][Full Text] [Related]
7. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease. Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880 [TBL] [Abstract][Full Text] [Related]
8. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients. Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440 [TBL] [Abstract][Full Text] [Related]
10. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. Takagi T; Naito Y; Inoue R; Kashiwagi S; Uchiyama K; Mizushima K; Tsuchiya S; Okayama T; Dohi O; Yoshida N; Kamada K; Ishikawa T; Handa O; Konishi H; Okuda K; Tsujimoto Y; Ohnogi H; Itoh Y J Clin Biochem Nutr; 2018 Jan; 62(1):100-105. PubMed ID: 29371761 [TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome. Singh A; Cresci GA; Kirby DF Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147 [TBL] [Abstract][Full Text] [Related]
12. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial. Zhu J; Sun C; Li M; Hu G; Zhao XM; Chen WH Gut; 2024 Jun; 73(7):1087-1097. PubMed ID: 38050061 [TBL] [Abstract][Full Text] [Related]
13. Influence of proton pump inhibitors on microbiota in chronic liver disease patients. Yamamoto K; Ishigami M; Honda T; Takeyama T; Ito T; Ishizu Y; Kuzuya T; Hayashi K; Goto H; Hirooka Y Hepatol Int; 2019 Mar; 13(2):234-244. PubMed ID: 30737678 [TBL] [Abstract][Full Text] [Related]
14. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients. Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821 [TBL] [Abstract][Full Text] [Related]
15. Oral microbiome alterations of healthy volunteers with proton pump inhibitor. Mishiro T; Oka K; Kuroki Y; Takahashi M; Tatsumi K; Saitoh T; Tobita H; Ishimura N; Sato S; Ishihara S; Sekine J; Wada K; Kinoshita Y J Gastroenterol Hepatol; 2018 May; 33(5):1059-1066. PubMed ID: 29105152 [TBL] [Abstract][Full Text] [Related]
16. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection. McDonald EG; Milligan J; Frenette C; Lee TC JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198 [TBL] [Abstract][Full Text] [Related]
17. Alterations in gut microbiota and bile acids by proton-pump inhibitor use and possible mediating effects on elevated glucose levels and insulin resistance. He Q; Xia B; Yang M; Lu K; Fan D; Li W; Liu Y; Pan Y; Yuan J FASEB J; 2024 Mar; 38(6):e23541. PubMed ID: 38498341 [TBL] [Abstract][Full Text] [Related]
18. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Seto CT; Jeraldo P; Orenstein R; Chia N; DiBaise JK Microbiome; 2014; 2():42. PubMed ID: 25426290 [TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors alter the composition of the gut microbiota. Jackson MA; Goodrich JK; Maxan ME; Freedberg DE; Abrams JA; Poole AC; Sutter JL; Welter D; Ley RE; Bell JT; Spector TD; Steves CJ Gut; 2016 May; 65(5):749-56. PubMed ID: 26719299 [TBL] [Abstract][Full Text] [Related]
20. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization. Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]